Filing Flows › RxSight (RXST) › Q2 2026
RxSight (RXST) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 5, 2026
RxSight (RXST) reported revenue of $33.7M for the second quarter 2026 (Q2 2026), +0.3% from a year earlier and +9% from the quarter before. Operating margin was -40.8%, net loss $12.1M (35.9% of revenue).
RxSight, Q2 2026: revenue $33.7M (+0.3% year over year), operating margin -40.8%, net loss $12.1M, operating cash flow −$9.5M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $33.7M | +9% | +0.3% |
| Operating profit | −$13.8M | — | — |
| Net earnings | −$12.1M | — | — |
| Operating cash flow | −$9.5M | — | — |
What changed
Revenue was $33.7M in Q2 2026, roughly flat year over year and up 9% from the previous quarter. Rxlal was the largest line at 73% of revenue. LDD declined 74%.
Operating costs exceeded revenue by $13.8M, an operating margin of -40.8%. The quarter ended with a net loss of $12.1M, narrower than the previous quarter's $15.9M loss.
Operating cash flow was −$9.5M. Non-cash charges added back $1.0M of depreciation and amortization and $7.5M of share-based compensation. Working capital and other items used $5.9M. Capital expenditures of $2.0M exceeded it, leaving free cash flow of −$11.5M.
Questions
What was RxSight's revenue in the second quarter 2026?
RxSight (RXST) reported revenue of $33.7M for the second quarter 2026 (Q2 2026), +0.3% from a year earlier and +9% from the quarter before.
Was RxSight profitable in the second quarter 2026?
Operating loss was $13.8M (-40.8% of revenue) and net loss $12.1M.
Source: RxSight 10-Q on SEC EDGAR.